Clincosm LogoSign in Get a demo

Optimizing CBT Implementation Among Community Providers Through Internet-based Consultation and Networking (i-CAN)

Sponsor
University of Alabama, Tuscaloosa (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05580081
Collaborator
(none)
100
Enrollment
2
Arms
18.5
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

Although anxiety is one of the most common and debilitating mental health conditions affecting children and adolescents, the vast majority of sufferers do not receive effective treatment. Cognitive-behavioral therapy (CBT) is an evidence-based, frontline treatment for pediatric anxiety, yet many community-based practitioners do not implement CBT with high fidelity, which can detrimentally affect its clinical impact. The goal of this study is to develop and test an online platform to support community providers' effective use of CBT for pediatric anxiety.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: i-CAN
 N/A

Detailed Description

Stemming from implementation science and, specifically, the Theory of Planned Behavior, investigators are working alongside community stakeholders to develop a novel, online consultation platform. This platform, termed Internet-based Consultation or Networking (or i-CAN) will utilize a professional navigator (i.e., a provider with CBT expertise), online support and resources, and parallel peer consultation to create a user-friendly and supportive community for providers to get support as they implement CBT. Once finalized, the platform will be tested in the context of a preliminary randomized controlled trial (RCT) with approximately 100 mental healthcare providers who work with anxious children and adolescents. Providers who enroll will be randomly assigned to either the experimental condition (i-CAN) or the control condition (wait-list for i-CAN). The primary outcome of interest is change in intentions to use CBT.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The RCT is a parallel group design, in which those in Control will be offered i-CAN after the 18 week waiting period.The RCT is a parallel group design, in which those in Control will be offered i-CAN after the 18 week waiting period.
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Optimizing CBT Implementation Among Community Providers Through Internet-based Consultation and Networking (i-CAN)
Anticipated Study Start Date :
Jan 15, 2023
Anticipated Primary Completion Date :
Mar 15, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: i-CAN

18 weeks of access to the online consulting platform

Behavioral: i-CAN
online support and consultation to providers
No Intervention: waitlit control

No offered support or consultation

Outcome Measures

Primary Outcome Measures

  1. Reasoned Action Questionnaire [18 weeks]

    questionnaire that assesses instrumental beliefs, perceived norms, and self-efficacy (all related to use of CBT)

Secondary Outcome Measures

  1. Evidence-based practice attitude scale [18 weeks]

    questionnaire that assesses views toward CBT

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • provide direct mental healthcare to anxious youth

  • practice in general community within state of Alabama

  • agree to try i-CAN

Exclusion Criteria:
  • None

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Alabama, Tuscaloosa

Investigators

  • Principal Investigator: Susan W White, PhD, UA

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Alabama, Tuscaloosa
ClinicalTrials.gov Identifier:
NCT05580081
Other Study ID Numbers:
  • A22-0473
First Posted:
Oct 14, 2022
Last Update Posted:
Oct 14, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 14, 2022